Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LJPC

La Jolla Pharmaceutical (LJPC) Stock Price, News & Analysis

La Jolla Pharmaceutical logo

About La Jolla Pharmaceutical Stock (NASDAQ:LJPC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$3.12
$6.22
52-Week Range
N/A
Volume
66,708 shs
Average Volume
158,476 shs
Market Capitalization
$155.11 million
P/E Ratio
51.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LJPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for La Jolla Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LJPC Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

LJPC Stock Analysis - Frequently Asked Questions

La Jolla Pharmaceutical (NASDAQ:LJPC) posted its quarterly earnings data on Monday, May, 16th. The biopharmaceutical company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.16. The biopharmaceutical company earned $10.43 million during the quarter, compared to analyst estimates of $13.10 million. La Jolla Pharmaceutical had a negative trailing twelve-month return on equity of 5.46% and a net margin of 8.54%.

Based on aggregate information from My MarketBeat watchlists, some other companies that La Jolla Pharmaceutical investors own include BioCryst Pharmaceuticals (BCRX), El Pollo Loco (LOCO), Intercept Pharmaceuticals (ICPT), Bristol Myers Squibb (BMY), Exelixis (EXEL), Sarepta Therapeutics (SRPT) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
5/16/2022
Today
9/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:LJPC
CIK
920465
Employees
61
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
$0.12
Trailing P/E Ratio
51.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$19.66 million
Net Margins
8.54%
Pretax Margin
8.64%
Return on Equity
-5.46%
Return on Assets
4.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.02
Quick Ratio
3.52

Sales & Book Value

Annual Sales
$75.72 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.95
Book Value
($2.94) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,937,000
Free Float
15,885,000
Market Cap
$155.11 million
Optionable
Optionable
Beta
2.39

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:LJPC) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners